The effect on bleeding complication occurred by hemostatic agents discontinuation in the percutaneous renal biopsy
Not Applicable
- Conditions
- kidney disease
- Registration Number
- JPRN-UMIN000022930
- Lead Sponsor
- ational Hospital Organization Kyoto Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who were punctured with bilateral kidney with sampling difficulty Patients who received erythrocyte transfusion before confirming hemoglobin concentration in four hours after renal biopsy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method